UK approves Pfizer-BioNTech vaccine for widespread use
The UK has approved the BNT162b2 vaccine developed by Pfizer and BioNTech for public use, becoming the first country to do so. Distribution will begin next week, starting with frontline healthcare workers and care home residents.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthUK approves Pfizer-BioNTech vaccine for widespread use
Sign in or subscribeBrowse free archive reportsThe UK has approved the BNT162b2 vaccine developed by Pfizer and BioNTech for public use, becoming the first country to do so. Distribution will begin next week, starting with frontline healthcare workers and care home residents.